Corcept Therapeutics (CORT) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $90.28 +3.83%
EPS Growth %: -96.6%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: -96.6%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $10.1 million versus the consensus estimate of $10.5 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- William Blair on TransMedics Group (TMDX): 'We believe TransMedics’ second-quarter sales will exceed consensus estimates'
- Lionsgate content momentum boosts outlook, but debt and valuation cap upside
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
